CONMED Income After Taxes 2010-2024 | CNMD

CONMED income after taxes from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
CONMED Annual Income After Taxes
(Millions of US $)
2024 $132
2023 $64
2022 $-81
2021 $63
2020 $10
2019 $29
2018 $41
2017 $55
2016 $15
2015 $30
2014 $32
2013 $36
2012 $40
2011 $1
2010 $30
2009 $12
CONMED Quarterly Income After Taxes
(Millions of US $)
2024-12-31 $34
2024-09-30 $49
2024-06-30 $30
2024-03-31 $20
2023-12-31 $33
2023-09-30 $16
2023-06-30 $14
2023-03-31 $2
2022-12-31 $27
2022-09-30 $46
2022-06-30 $-168
2022-03-31 $15
2021-12-31 $24
2021-09-30 $15
2021-06-30 $13
2021-03-31 $10
2020-12-31 $24
2020-09-30 $7
2020-06-30 $-27
2020-03-31 $6
2019-12-31 $15
2019-09-30 $7
2019-06-30 $6
2019-03-31 $1
2018-12-31 $16
2018-09-30 $6
2018-06-30 $9
2018-03-31 $11
2017-12-31 $47
2017-09-30 $7
2017-06-30 $6
2017-03-31 $-5
2016-12-31 $7
2016-09-30 $7
2016-06-30 $3
2016-03-31 $-2
2015-12-31 $8
2015-09-30 $9
2015-06-30 $7
2015-03-31 $6
2014-12-31 $11
2014-09-30 $2
2014-06-30 $10
2014-03-31 $9
2013-12-31 $10
2013-09-30 $6
2013-06-30 $10
2013-03-31 $10
2012-12-31 $11
2012-09-30 $9
2012-06-30 $10
2012-03-31 $10
2011-12-31 $-25
2011-09-30 $8
2011-06-30 $9
2011-03-31 $9
2010-12-31 $7
2010-09-30 $9
2010-06-30 $7
2010-03-31 $7
2009-12-31 $5
2009-09-30 $1
2009-06-30 $1
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.583B $1.307B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.641B 24.25
Becton Dickinson (BDX) United States $59.276B 14.84
Cardinal Health (CAH) United States $33.781B 18.09
Labcorp (LH) United States $20.116B 16.32
Straumann Holding AG (SAUHY) Switzerland $19.852B 0.00
Cooper (COO) United States $16.444B 21.81
West Pharmaceutical Services (WST) United States $15.336B 32.15
Align Technology (ALGN) United States $13.013B 25.21
Henry Schein (HSIC) United States $8.105B 13.96
Merit Medical Systems (MMSI) United States $5.600B 27.07
DENTSPLY SIRONA (XRAY) United States $2.780B 8.35
STAAR Surgical (STAA) United States $0.918B 0.00
Pro-Dex (PDEX) United States $0.217B 33.03
Lifevantage (LFVN) United States $0.155B 17.15